WO2000073415A3 - A method for the transfer of antigens to dendritic cells - Google Patents
A method for the transfer of antigens to dendritic cells Download PDFInfo
- Publication number
- WO2000073415A3 WO2000073415A3 PCT/EP2000/004712 EP0004712W WO0073415A3 WO 2000073415 A3 WO2000073415 A3 WO 2000073415A3 EP 0004712 W EP0004712 W EP 0004712W WO 0073415 A3 WO0073415 A3 WO 0073415A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- transfer
- dendritic cells
- antigens
- cells
- cocultivation
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 3
- 102000036639 antigens Human genes 0.000 title abstract 3
- 108091007433 antigens Proteins 0.000 title abstract 3
- 210000004443 dendritic cell Anatomy 0.000 title abstract 2
- 210000004027 cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4615—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/464402—Receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/464484—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
- A61K39/464486—MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/464496—Fusion proteins originating from gene translocation in cancer cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/57—Skin; melanoma
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/05—Adjuvants
- C12N2501/052—Lipopolysaccharides [LPS]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/99—Coculture with; Conditioned medium produced by genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cell Biology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002375349A CA2375349A1 (en) | 1999-05-28 | 2000-05-24 | A method for the transfer of antigens to dendritic cells |
JP2001500731A JP2003501019A (en) | 1999-05-28 | 2000-05-24 | Transferring antigens to dendritic cells |
EP00936788A EP1185626A2 (en) | 1999-05-28 | 2000-05-24 | A method for the transfer of antigens to dendritic cells |
AU52159/00A AU772703B2 (en) | 1999-05-28 | 2000-05-24 | A method for the transfer of antigens to dendritic cells |
KR1020017015173A KR20020013563A (en) | 1999-05-28 | 2000-05-24 | A method for the transfer of antigens to dendritic cells |
IL14677700A IL146777A0 (en) | 1999-05-28 | 2000-05-24 | A method for the transfer of antigens to dendritic cells |
HK02108610.1A HK1047131A1 (en) | 1999-05-28 | 2002-11-29 | A method for the transfer of antigens to dendritic cells |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI99A001180 | 1999-05-28 | ||
IT1999MI001180A IT1312570B1 (en) | 1999-05-28 | 1999-05-28 | METHOD FOR TRANSFER OF DENDRITIC CELL ANTIGENS. |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000073415A2 WO2000073415A2 (en) | 2000-12-07 |
WO2000073415A3 true WO2000073415A3 (en) | 2001-03-01 |
Family
ID=11383060
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/004712 WO2000073415A2 (en) | 1999-05-28 | 2000-05-24 | A method for the transfer of antigens to dendritic cells |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1185626A2 (en) |
JP (1) | JP2003501019A (en) |
KR (1) | KR20020013563A (en) |
CN (1) | CN1187442C (en) |
AU (1) | AU772703B2 (en) |
CA (1) | CA2375349A1 (en) |
HK (1) | HK1047131A1 (en) |
IL (1) | IL146777A0 (en) |
IT (1) | IT1312570B1 (en) |
WO (1) | WO2000073415A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6506596B2 (en) | 2000-06-01 | 2003-01-14 | Anna-Lena Spetz-Holmgren | Method of DNA transfer |
CN100392074C (en) * | 2003-10-15 | 2008-06-04 | 上海海欣生物技术有限公司 | Dendritic cell tumor vaccine and its preparation and use |
KR20150032915A (en) * | 2005-04-08 | 2015-03-30 | 아르고스 쎄라퓨틱스 인코포레이티드 | Dendritic cell compositions and methods |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995006723A1 (en) * | 1993-09-01 | 1995-03-09 | Boehringer Mannheim Gmbh | Method of marking eukaryotic cells by the use of a cell surface receptor as a marker |
WO1995034638A1 (en) * | 1994-06-14 | 1995-12-21 | The Board Of Trustees Of Leland Stanford Junior University | Methods for in vivo t cell activation by antigen-pulsed dendritic cells |
US5871728A (en) * | 1995-03-31 | 1999-02-16 | University Of Pittsburgh | Method of regulating dendritic cell maturation |
EP0904786A1 (en) * | 1997-08-22 | 1999-03-31 | Science Park Raf S.p.A. | Tumor vaccination by the use of antigen transduced autologous cells |
WO1999042564A2 (en) * | 1998-02-20 | 1999-08-26 | The Rockefeller University | Apoptotic cell-mediated antigen presentation to dendritic cells |
-
1999
- 1999-05-28 IT IT1999MI001180A patent/IT1312570B1/en active
-
2000
- 2000-05-24 IL IL14677700A patent/IL146777A0/en unknown
- 2000-05-24 CN CNB008081557A patent/CN1187442C/en not_active Expired - Fee Related
- 2000-05-24 KR KR1020017015173A patent/KR20020013563A/en not_active Application Discontinuation
- 2000-05-24 EP EP00936788A patent/EP1185626A2/en not_active Withdrawn
- 2000-05-24 AU AU52159/00A patent/AU772703B2/en not_active Ceased
- 2000-05-24 JP JP2001500731A patent/JP2003501019A/en active Pending
- 2000-05-24 WO PCT/EP2000/004712 patent/WO2000073415A2/en not_active Application Discontinuation
- 2000-05-24 CA CA002375349A patent/CA2375349A1/en not_active Abandoned
-
2002
- 2002-11-29 HK HK02108610.1A patent/HK1047131A1/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995006723A1 (en) * | 1993-09-01 | 1995-03-09 | Boehringer Mannheim Gmbh | Method of marking eukaryotic cells by the use of a cell surface receptor as a marker |
WO1995034638A1 (en) * | 1994-06-14 | 1995-12-21 | The Board Of Trustees Of Leland Stanford Junior University | Methods for in vivo t cell activation by antigen-pulsed dendritic cells |
US5871728A (en) * | 1995-03-31 | 1999-02-16 | University Of Pittsburgh | Method of regulating dendritic cell maturation |
EP0904786A1 (en) * | 1997-08-22 | 1999-03-31 | Science Park Raf S.p.A. | Tumor vaccination by the use of antigen transduced autologous cells |
WO1999042564A2 (en) * | 1998-02-20 | 1999-08-26 | The Rockefeller University | Apoptotic cell-mediated antigen presentation to dendritic cells |
Non-Patent Citations (5)
Title |
---|
ALBERT ET AL: "Resurrecting the dead: DCs cross-present antigen derived from apoptotic cells on MHC I", IMMUNOLOGIST,CA,HOGREFE AND HUBER PUBLISHERS, TORONTO, vol. 6, no. 5, September 1998 (1998-09-01), pages 194 - 198, XP002119454, ISSN: 1192-5612 * |
ALBERT MATTHEW L ET AL: "Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs.", NATURE (LONDON), vol. 392, no. 6671, 5 March 1998 (1998-03-05), pages 86 - 89, XP002154749, ISSN: 0028-0836 * |
RUSSO V ET AL: "Acquisition of intact allogeneic HLA molecules by human dendritic cells.", BLOOD, vol. 94, no. 10 SUPPL. 1 PART 1, 15 November 1999 (1999-11-15), Forty-first Annual Meeting of the American Society of Hematology;New Orleans, Louisiana, USA; December 3-7, 1999, pages 678a, XP002154751, ISSN: 0006-4971 * |
RUSSO V ET AL: "Cocultivation of non-diving dendritic cells with a retroviral vector-producing cell line allows transfer of the relevant antigens by a vector-independent mechanism.", BLOOD, vol. 92, no. 10 SUPPL. 1 PART 1-2, 15 November 1998 (1998-11-15), 40th Annual Meeting of the American Society of Hematology;Miami Beach, Florida, USA; December 4-8, 1998, pages 667A, XP000971149, ISSN: 0006-4971 * |
RUSSO VINCENZO ET AL: "Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 97, no. 5, 29 February 2000 (2000-02-29), Feb. 29, 2000, pages 2185 - 2190, XP002154750, ISSN: 0027-8424 * |
Also Published As
Publication number | Publication date |
---|---|
AU772703B2 (en) | 2004-05-06 |
CN1187442C (en) | 2005-02-02 |
JP2003501019A (en) | 2003-01-14 |
IT1312570B1 (en) | 2002-04-22 |
WO2000073415A2 (en) | 2000-12-07 |
CN1360628A (en) | 2002-07-24 |
KR20020013563A (en) | 2002-02-20 |
HK1047131A1 (en) | 2003-02-07 |
IL146777A0 (en) | 2002-07-25 |
AU5215900A (en) | 2000-12-18 |
EP1185626A2 (en) | 2002-03-13 |
ITMI991180A1 (en) | 2000-11-28 |
CA2375349A1 (en) | 2000-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001282123A1 (en) | Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells | |
HK1048122A1 (en) | Method for the preparation of citalopram. | |
AU1292700A (en) | Immune cells having predefined biological specificity, comprising chimeric t cell receptor | |
ZA200108855B (en) | Method for the preparation of citalopram. | |
HK1049002A1 (en) | Method for the preparation of citalopram. | |
AU3198200A (en) | Prrsv vaccines | |
AU7445900A (en) | Novel hemopoietin receptor protein, nr12 | |
HK1044342A1 (en) | Method for the preparation of 5-cyanophthalide. | |
AU2002230470A1 (en) | Process for preparing pouches | |
HK1047086A1 (en) | Method for the preparation of citalopram. | |
HK1054378A1 (en) | Method for the preparation of citalopram. | |
EP1156042A4 (en) | Process for the preparation of glycerol carbonate | |
AUPQ485999A0 (en) | P. gingivalis antigenic composition | |
WO2001040242A3 (en) | 6-o-methylerythromycin a crystal form iii | |
AU2001294577A1 (en) | Methods for preparing interferon producing dentitric cells | |
ZA200007458B (en) | Method of preparing a fuel cell. | |
HK1046443A1 (en) | Rate adjusting method for mechanical timepieces. | |
AU1962600A (en) | Antibodies binding to the aav capsid, antibodies modifying cytotropism, method for targeted gene transfer | |
AU1097301A (en) | Humanization of non-human, mammalian antibodies | |
AU5577800A (en) | Method for producing cloned cows | |
WO2000073415A3 (en) | A method for the transfer of antigens to dendritic cells | |
AU6726598A (en) | Method for generating embryogenic cell cultures for the production of transgenicbananas (musa spp.) | |
AU2002223541A1 (en) | Deltamethrin-containing, water-dispersible granular material | |
AU5585700A (en) | Process for making 2,4,6, 8,10,12- hexanitro- 2,4,6,8,10, 12- hexa azatetracyclo(5.5.0. 05,9.03,11} -dodecane | |
AU5540900A (en) | Novel method for preparing optically active alpha-aminonitriles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 00808155.7 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2000936788 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2001 500731 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2375349 Country of ref document: CA Ref document number: 2375349 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020017015173 Country of ref document: KR Ref document number: 52159/00 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09979308 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1020017015173 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2000936788 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 52159/00 Country of ref document: AU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000936788 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1020017015173 Country of ref document: KR |